Vaccination Recommendations for Adults Receiving Biologics and Oral Therapies for Psoriasis and Psoriatic Arthritis: Delphi Consensus from the Medical Board of the National Psoriasis Foundation
abatacept, acitretin, adalimumab, apremilast, biologics, brodalumab, certolizumab, cyclosporine, deucravacitinib, etanercept, golimumab, guselkumab, infliximab, ixekizumab, methotrexate, psoriasis, psoriatic arthritis, recommendation, risankizumab, secukinumab, tildrakizumab, tofacitinib, ustekinumab, vaccination, vaccines,
Related Posts
Tang HS, Ebriani J, Yan MJ, Wongvibulsin S, Farshchian M. Artificial Intelligence in Patch Testing: Comprehensive Review of Current Applications and Future Prospects in Dermatology.[...]
Nolan N, Mitchell M, Mboning L, Bouchard LS, Pellegrini M. MicroBayesAge: a maximum likelihood approach to predict epigenetic age using microarray data. Geroscience. 2025 May[...]
Lapitan C, Zhang WR, Guo B, Daniels-Wells TR, Penichet ML, Zhang K. Characterization of IgE cross-reactivity and allergenicity of peanut allergens. Immunohorizons. 2025 May 30;9(7):vlaf018.[...]